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SUMMARY OF THESIS*
RUBINSKY-ELEFANT, Guita - Toxocaríase humana: avaliação dos níveis de anticorpos IgG, IgA e IgE anti-Toxocara canis e correlação
clínico-laboratorial em pacientes submetidos à terapêutica. São Paulo, 2004. (Tese de Doutorado - Instituto de Ciências Biomédicas da
Universidade de São Paulo).
HUMAN TOXOCARIASIS: HUMORAL RESPONSE (IgG, IgA AND IgE) ANTI-Toxocara canis AND
CLINICAL-LABORATORIAL CORRELATION IN PATIENTS FOLLOWING CHEMOTHERAPY
A serological follow-up was carried out in 27 children with
toxocariasis (23 with visceral, 3 with both visceral and ocular
manifestations and 1 with ocular toxocariasis, a total of 159 samples),
treated with thiabendazole. The ages of the children varied from 1 to 12
years (average of 4.2 years), and the follow up treatment varied from 22
to 116 months (average of 65 months). The enzyme linked
immunosorbent assay (ELISA) and Western blotting technique for the
detection of specific IgG, IgA and IgE anti-Toxocara were standardized,
using excretory-secretory antigen obtained from Toxocara canis second
stage larvae culture. The avidity of specific antibodies IgG was also
evaluated in both tests.
The sensitivity of ELISA IgG, IgA and IgE were 100%, 47.8% and
78.3% respectively, in visceral toxocariais patients. The humoral immune
response was stronger in these patients compared to those with ocular
manifestations. Although 84% of the patients presented one or more
parasites in feces, the number of parasites did not affect the specific
humoral response. In the follow-up after treatment, the first isotype that
showed significant differences in titers was IgE antibodies, in the first
year. Specific IgA showed differences in the second year and specific
IgG, in the fourth year after treatment. Although the decrease of IgG
titers was observed, the levels still remained elevated for many years.
All patients presented high avidity IgG antibodies, in both ELISA and
WB tests, pointing to a chronic phase of the disease.
The WB technique was performed with gradient polyacrilamide gel
(5-15%), showing a pattern of bands ranging from 29 to >205 kDa, with
the predominance of the 29-38 and 48-54 kDa bands. WB-IgG showed
the highest sensitivity (100%), followed by IgE (91.3%) and IgA (73.9%).
The WB profile could be divided in two groups: a constant pattern of
bands throughout the follow-up study and another that presented a
decrease in reactivity to some bands. A decrease statistically significant
was seen in the pattern of WB-IgG reactivity to bands >205 kDa in the
third year and in WB-IgA to bands 81-93, 66, 48-54 and 29-38 kDa, in
the first year after treatment.
The evaluation of laboratorial data showed a decrease statistically
significant in the number of leukocytes, titers of isohaemagglutinins anti-
A and absolute number of eosinophils, in patients with visceral
toxocariasis, one year after treatment. In patients with ocular
manifestation, the number of leukocytes and eosinophils were normal.
At the beginning of the study, hypergammaglobulinemia was observed
as well high levels of antibodies IgE and IgM. There was a correlation
between the titers of specific IgE and the number of eosinophils, as well
as correlation between total and specific IgG.
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